Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI
Adriana K Cushnie
, Daniel N. Bullock
,
Ana M.G. Manea
, Wei Tang
,
Jan Zimmermann
, Sarah R. Heilbronner
Neuroscience
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nonhuman Primate
100%
Functional Magnetic Resonance Imaging
100%
Actuator
100%
Chemogenetics
100%
DREADD
100%
Clozapine
66%
Deschloroclozapine
66%
Resting-state Functional Connectivity (rs-FC)
44%
Intrinsic Neural Timescales
44%
Nave
22%
Behavior Change
11%
High Dose
11%
Functional Properties
11%
Rodents
11%
Physiological Changes
11%
Drug-induced
11%
Cell Behavior
11%
Subject-specific
11%
Highly Selective
11%
Drug Administration
11%
Ligand Effects
11%
Endogenous Receptors
11%
Systemic Medications
11%
Off-target Effects
11%
Engineered Receptors
11%
Neuroscience
Functional Magnetic Resonance Imaging
100%
Receptor
100%
Designer Drug
100%
Clozapine
54%
Resting-State Functional Connectivity
36%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Designer Drug
100%
Clozapine
54%
Drug Administration
9%